Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa

September 25, 2025 updated by: Laureate Institute for Brain Research, Inc.
The proposed study utilizes a randomized experimental therapeutics design to test a mechanistic framework linking interoceptive processing and disturbed body image, with the purpose of informing the development of future therapies for body image dissatisfaction in anorexia nervosa (AN). A sample of 102 participants will be recruited from the Laureate Eating Disorder Program (LEDP). After being randomized, participants will all receive a one-hour session of acceptance- and mindfulness-based training with a therapist (the introduction session). They will then receive either the interoceptively focused treatment (IFT) or exteroceptively focused treatment (EFT) condition based on randomization. In the IFT condition participants will engage in floatation-REST (Reduced Environmental Stimulation Therapy) while practicing acceptance and mindfulness-based principles. The EFT condition is an exteroceptive intervention in which participants will be asked to view pre-recorded videos of acceptance and mindfulness-based skills to aid in the practice of these skills. Each condition will consist of one introduction session and three experimental sessions. All participants will then return for follow-up measures. Assessed outcomes will include acute changes in body image disturbance (BID) and interoception. Further, longitudinal intervention effects on self-reported eating disorder symptoms, body image dissatisfaction, and interoception; behavioral measures of interoception and body image dissatisfaction; and resting state and interoceptive functioning during functional magnetic resonance imaging (fMRI) will be explored.

Study Overview

Detailed Description

Anorexia nervosa (AN) accounts for more than 10,000 deaths per year in the United States alone, marking it as a psychiatric disorder with one of the highest standardized mortality rates. Current AN treatments have only moderate efficacy and result in relapse rates as high as 50% within one year of hospitalization. A poor understanding of the pathophysiology of AN, particularly the core diagnostic feature of body image disturbance (BID), has hindered treatment development. Abnormal interoceptive processing (i.e., internal body signal) has been proposed to contribute to BID and a mechanistic delineation of the association between interoception and BID could lead to novel interventions for AN. This proposal uses a behavioral experimental therapeutics approach to determine how modulating interoceptive processing affects BID in AN.

Body image, defined as the multifaceted experience of one's physical appearance, is comprised of cognitive, affective, and perceptual components. BID is a key diagnostic feature of AN that is associated with poor outcomes, including relapse following hospital discharge. It is slow to improve in women with AN, and has been consistently identified as a factor contributing to the persistence of AN symptoms and relapse following treatment.

Perceptual BID is a complex and poorly understood facet proposed to involve the integration of body-related visual signals with representations of interoceptive signals. Studies indicate women with AN overestimate their body size. Standard of care treatments for AN, such as Cognitive Behavioral Therapy, focus on modifying the cognitive/affective components of BID but rarely address the perceptual component, making it an under-investigated therapeutic target.

Diminished sensitivity to interoceptive body signals in AN may lead to an overreliance on exteroceptive (i.e., visual) body-related signals, which in turn, is likely to facilitate self-objectification (seeing one's body as an object). The outcome of this process is an inaccurate representation of physical body characteristics (i.e., perceiving one's body as larger than its true size) despite continuing to focus on it excessively. To explore whether the modulation of interoceptive signaling could improve perceptual BID in AN, we recently utilized a non-pharmacologic intervention called floatation-REST (Reduced Environmental Stimulation Therapy). During floatation-REST, input from visual, auditory, olfactory, gustatory, thermal, tactile, vestibular and proprioceptive channels are minimized, and interoceptive input is enhanced. Across two clinical trials in AN we have found that floatation-REST acutely reduces perceptual BID, indexed by the body dissatisfaction score on the Photographic Figure Rating Scale (PFRS), after one session and reliably after multiple sessions.

Acceptance and commitment therapy (ACT) for eating disorders and body image has been examined previously and evidence supports the reduction of cognitive/affective BID symptoms. The proposed study will combine floatation-REST with interoceptively focused acceptance- and mindfulness-based components (interoceptively focused therapy [IFT]). The primary purpose of the proposed study is to examine the acute synergistic effects of IFT and float on BID. Further, the proposed study will be the first to systematically examine associations between BID and interoception using multiple levels of analysis (i.e., self-report and behavioral assays and neuroimaging) and combine them with perturbations of interoceptive and cognitive processing to examine the impact of interoception on perceptual BID. All participants will receive a one-hour introduction session prior to being randomized on a 1:1 basis to receive three 45-minute floatation-REST sessions (to attenuate exteroceptive input and enhance interoceptive input) paired with IFT or three 45-minute self-guided exteroceptive practice sessions (active comparator to enhance cognitive/affective BID, EFT group). During the IFT/EFT sessions the skills presented have been matched as closely as possible with the exception of the focus. For example, both groups engage in contact with the present moment exercises. In the IFT group, the focus is internal body sensations; whereas in the EFT group, the focus in the experience outside the individual (e.g., their environment sights, sounds, etc). While ACT is typically conducted in longer intervals (10+ weeks of 1 hour sessions), there is growing evidence to support the potential of briefer ACT interventions.

Both groups will complete behavioral and self-report assays of interoception, perceptual and cognitive/affective BID, and state/trait illness measures pre- and post-experimental session; pre and post intervention measures including self-report, behavioral, and neurobiological assays (specifically functional magnetic resonance imaging); and longitudinal follow-ups. The ability to reliably improve BID marks a step forward in the search for more effective BID treatments for AN. Given that it is expected that acceptance and mindfulness-based components will impact affective components of body image, it is expected that there will be an additive effect on the primary outcome (perceptual BID).

Study Type

Interventional

Enrollment (Estimated)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Primary diagnosis of anorexia nervosa
  2. Photographic Figure Rating Scale (PFRS) body dissatisfaction score greater than or equal to 1
  3. Eating Disorder Examination Questionnaire (EDE-Q6) Shape Concern Subscale score greater than or equal to 3
  4. Weight restored to body mass index (BMI) greater than or equal to 17.5
  5. No current evidence of orthostatic hypotension or if there is no evidence of additional fall risk as determined by their provider
  6. Clinical status transition from acute to residential status
  7. No new psychiatric medications in the week prior to randomization
  8. Female sex assigned at birth
  9. Ages 13 to 50 years
  10. Independently ambulatory
  11. Ability to lay flat comfortably
  12. English proficiency
  13. Willingness and ability to participate in study procedures
  14. Provision of informed consent (parent consent and minor assent if less than 18 years of age).

Exclusion Criteria:

  1. Active suicidal ideation with plan and intent
  2. Active cutting or skin lacerating behaviors
  3. Pregnancy as defined by urine screening
  4. Acute intoxication as indicated by urine drug screen or breathalyzer
  5. Orthostatic hypotension as determined by medical provider, evidenced in chart (defined as a drop of ≥ 20 mmHg in systolic blood pressure (BP) or a drop of ≥ 10 mm Hg in diastolic blood pressure (BP) when measured shortly after transitioning from lying down to standing). If evidence of orthostasis is present in chart consultation with provider to determine if status creates additional fall risk. If participant is determined to be at increased fall risk (e.g., dizziness upon standing) they will be excluded.
  6. Seizure reported within the previous 12 months
  7. Co-morbid diagnoses of Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) bipolar disorder, schizophrenia, or other psychosis spectrum disorder
  8. Systolic blood pressure > 160 mmHg
  9. Diastolic blood pressure >100 mmHg
  10. Resting heart rate <50 beats per minute.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interoceptively Focused Treatment (IFT)
The IFT intervention will guide participants through a tailored application of present-moment focus toward experiencing awareness and acceptance of bodily signals and defusing thoughts related to those signals. For example, participants will engage in several exercises to increase awareness of body sensations, thoughts, and emotions. IFT consists of one introduction session with a clinician (~60 minutes) the introduction session was designed as a brief introduction to acceptance- and mindfulness-based concepts with guided practice exercises and closing time for participants to briefly process challenges to execution of exercises and the experience during the session. This is followed by three IFT sessions which combine acceptance- and mindfulness-based skills practice with floatation-REST (Reduced Environmental Stimulation Therapy via floatation).
Participants lay supine in one of two circular fiberglass pools that were custom-designed for research purposes. The floatation pools are 8 feet in diameter and contain 11 inches of reverse osmosis water saturated with ~1,800 pounds of Epsom salt (magnesium sulfate). This creates a dense saltwater solution with a specific gravity of ~1.26, allowing participants to effortlessly float on their back while the water hovers just above the ears. The temperature of the water and air is calibrated to approximate skin temperature (~95.0 °F), helping to minimize the need for thermoregulation while reducing the boundary between air, body, and water. Clothing is usually not worn while floating since anything touching the body can generate somatosensory stimulation, detracting from the float experience. However, participants have the option to choose if they would prefer to float with a bathing suit or nude. During floatation-REST, visual, auditory, olfactory stimuli are minimized.
Two ACT principles, contact with the present moment and cognitive defusion were utilized in the development of the intervention. In the IFT condition, awareness and acceptance of bodily signals, thoughts, and emotions and being present with one's self (i.e., mindfulness focus is inward) are emphasized. All participants will engage in an introduction session. Followed by three IFT sessions. The experimental sessions are formatted the same for both conditions. Each begins with a clinician reviewing previous constructs and introducing a new skill. Then participants engage in their assigned condition intervention, followed by a debrief with a clinician. Practices in both conditions are matched as closely as possible for content. The mindful focus of IFT is internal toward thoughts, emotions, and body sensations. In the experimental sessions, participants will engage in a floatation-REST session while practicing acceptance and mindfulness-based skills presented to them.
Other Names:
  • acceptance- and mindfulness based intervention
Active Comparator: Exteroceptively Focused Treatment (EFT)
In the EFT condition, exercises are tailored toward experience of the present moment via external environment mindfulness (i.e., attending to experience) and defusion of thoughts. EFT consists of one introduction session with a clinician (~60 minutes) the introduction session, similar in format to IFT, introduces acceptance- and mindfulness-based concepts. This is followed by three EFT sessions during which participants engage in brief guided skills training followed by video guided skills practice. The EFT condition is designed to increase awareness of the present moment and experience of the environment and view thoughts or emotions that may impact engagement with the current moment in a nonjudgmental way.
Two acceptance and commitment therapy modules contact with the present moment and cognitive defusion were utilized in the development of the intervention. In the EFT condition, awareness and acceptance of thoughts and emotions and mindfulness of current experience are emphasized. The mindful focus of EFT is external, toward attending to experience as well as thoughts and emotions. During experimental sessions, participants will engage in a self-guided and computer-based practice of acceptance and mindfulness-based skills. These videos were created to ensure content was congruent with the material presented in the introduction sessions and represent skills that build from session to session.
Other Names:
  • acceptance- and mindfulness based intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceptual body image dissatisfaction on the Photographic Figure Rating Scale (PFRS)
Time Frame: Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Average change in acute body image dissatisfaction from pre- to post-experimental sessions across all three sessions (range 0 - 9, larger changes indicate greater severity of BID)
Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Perceptual body image dissatisfaction on the Photographic Figure Rating Scale (PFRS)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in BID from pre- to post-intervention (range 0 - 9, larger changes indicate greater severity of BID).
Through completion of post-intervention follow-up, within 2 weeks of final intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive/affective body image on the Body Image State Scale (BISS)
Time Frame: Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Average of the change in state cognitive affective body image state pre- to post-experimental sessions across all three sessions. Items 2,4,6 are reverse coded (range 1 to 9, higher scores indicate greater satisfaction with body image)
Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Body image dissatisfaction on the Somatomap3D
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average of the change in anxiety rating from pre- to post-intervention sessions (measured in difference size estimation from Somatomap3D current to ideal in cm, larger discrepancy indicates greater body dissatisfaction)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Appearance evaluation on the Multidimensional Body-Self Relations Questionnaire- Appearance Scales (MBSRQ-AS) Appearance Evaluation Subscale (range 7 to 35, higher scores indicate more satisfaction with appearance)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average of the change in appearance evaluation rating from pre- to post-intervention sessions
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Appearance orientation on the Multidimensional Body-Self Relations Questionnaire- Appearance Scales (MBSRQ-AS) Appearance Orientation Subscale (range 7 to 35, higher scores indicate more satisfaction with appearance)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average of the change in appearance orientation rating from pre- to post-intervention sessions (range 12 to 60, higher scores indicate more importance placed on appearance).
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Body image satisfaction on the Multidimensional Body-Self Relations Questionnaire- Appearance Scales (MBSRQ-AS) Body Areas Satisfaction
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average of the change in body image satisfaction rating from pre- to post-intervention sessions (scores range from 9 to 45, higher scores indicate more content with body appearance)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Overweight preoccupation on the Multidimensional Body-Self Relations Questionnaire- Appearance Scales (MBSRQ-AS) Overweight preoccupation scale
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average of the change in preoccupations with gaining weight from pre- to post-intervention sessions (scores range from 4 to 20, higher scores indicate higher preoccupation)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Noticing on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in awareness of body sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate more self-reported awareness of body sensations)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Not distracting on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in extent one distracts from unpleasant sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate more adaptive response to unpleasant body sensations)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Not worrying on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in extent one worries about unpleasant physical sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate less rumination about unpleasant body sensations)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Attention regulation on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in ability to sustain and control attention to body sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate less rumination about unpleasant body sensations)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Emotional awareness on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in ability to awareness and connection between body and emotional states from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate more awareness of the connection between emotion and body states)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Self-regulation on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in ability to regulate distress through attention to body sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate more regulation)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Trust on the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in experiences of one's body as safe and trustworthy ability to regulate distress through attention to body sensations from pre- to post-intervention sessions (scores range from 0 to 5, higher scores indicate more trust in body)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Interoceptive attention on the Interoceptive Attention Scale (IATS)
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Average change in attention to interoceptive signals from pre- to post-intervention sessions (scores range from 21 to 105, higher scores indicate greater self-reported attention to internal signals)
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Cardiac interoceptive accuracy on the Heartbeat Tapping Task
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Beat-to-tap consistency measure of the Heartbeat Tapping Task, higher values indicate greater consistency between actual heartbeats and perceived heartbeats.
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Cardiac interoceptive intensity on the Heartbeat Tapping Task
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Intensity of cardiac signals measured via visual analog scale during the Heartbeat Tapping Task, higher values indicate greater intensity of perceived heartbeats.
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Interoceptive intensity during experimental conditions
Time Frame: Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Intensity of cardiac, respiratory, and gastric signals measured via visual analog scale pre-to -post experimental conditions, higher values indicate greater intensity
Through completion of experimental sessions, 2-4 weeks after pre-treatment baseline completion
Perceived respiratory interoceptive intensity on the Breath Hold Task
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Intensity of panic, suffocation, and anxiety during breath hold task measured via visual analog scale pre-to -post experimental conditions, higher values indicate greater intensity
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Body image distortion on the Aperture Task
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Absolute difference between perceived size gap to fit through the aperture and actual shoulder width to pass through
Through completion of post-intervention follow-up, within 2 weeks of final intervention
Body image distortion on the String task
Time Frame: Through completion of post-intervention follow-up, within 2 weeks of final intervention
Sum of the absolute difference between perceived body part size measured via string task and actual body size
Through completion of post-intervention follow-up, within 2 weeks of final intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily M Choquette, PhD, Laureate Institute for Brain Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2024

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

March 20, 2024

First Submitted That Met QC Criteria

March 20, 2024

First Posted (Actual)

March 27, 2024

Study Record Updates

Last Update Posted (Estimated)

September 26, 2025

Last Update Submitted That Met QC Criteria

September 25, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Floatation-REST

Subscribe